GT
CORZ icon

Glenmede Trust’s Core Scientific CORZ Stock Holding History

Glenmede Trust’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.78M Buy
69,417
+15,777
+29% +$371K 0.01% 614
2026
Q1 		$802K Buy
53,640
+31,943
+147% +$545K ﹤0.01% 806
2025
Q4 		$316K Buy
+21,697
New +$378K ﹤0.01% 1118
2025
Q1 		$320K Buy
44,237
+3,244
+8% +$36.9K ﹤0.01% 1061
2024
Q4 		$576K Buy
+40,993
New +$606K ﹤0.01% 887

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
JCAM
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return

Glenmede Trust's CORZ Position: Q2 2026 in Review

Glenmede Trust increased its Core Scientific (CORZ) stake by 29% in Q2 2026, buying an estimated $371K and bringing the position to 69,417 shares worth $1.78M. The position accounts for 0.01% of the portfolio, ranked #614.

Glenmede Trust first reported a position in CORZ in Q4 2024 and has held it in 5 quarters since. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Glenmede Trust held 69,417 shares of Core Scientific worth $1.78M as of Q2 2026.
  • Glenmede Trust bought 15,777 Core Scientific shares in Q2 2026, an estimated $371K.
  • Core Scientific made up 0.01% of Glenmede Trust's portfolio in Q2 2026, its #614 holding.
  • Glenmede Trust first reported a position in Core Scientific in Q4 2024 and has held it in 5 quarters since.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Glenmede Trust's 13F filing for Q2 2026, filed 10 Aug 2026.